Long-term methadone treatment can affect the brain

March 23, 2011

Methadone has been used to treat heroin addicts for nearly 50 years. Yet we have surprisingly incomplete knowledge about possible harmful effects from prolonged use. New research from the Norwegian Institute of Public Health shows that methadone affects the brain and impairs the attention of experimental animals.

In general, such as heroin and are known to weaken intellectual functions such as learning, memory and attention.

"It is therefore tempting to assume that methadone has similar effects," says researcher Jannike M. Andersen at the NIPH's Division of Forensic Toxicology and .

For ethical reasons, methadone cannot be tested in long-term studies of healthy volunteers. It is also difficult to draw reliable conclusions from studies with methadone patients, because these studies often encounter methodological problems. Therefore, animals were used in the research.

New study of methadone

In a new study, Andersen and colleagues treated rats daily with methadone for three weeks and studied the rats' attention. The researchers measured how long the rats examined a new object introduced into their cage. The results show that the treatment clearly reduced the attention of the animals. This was true both when the had methadone in the body and, more importantly - a day after the last treatment, when the methadone had been excreted.

"The fact that the attention is impaired even after the drug was no longer present in the body suggests that methadone causes changes in . We do not yet know exactly what the changes are and how long-lasting they will be" says Andersen.

Is the human brain affected too?

-Does this unwanted effect have significance for people who are treated with methadone over many years?

"A positive treatment outcome depends on the patient functioning well - both socially and intellectually. If methadone treatment also impairs intellectual functions in humans, it could have a negative effect on the treatment result.

"We must now follow up the results from the animal studies to see if attention problems persist and to learn more about the biological mechanisms involved. Only then can we say anything more about the translation value of our findings for humans," says Andersen.

Methadone is a synthetic opioid that has been used in the treatment of heroin addicts worldwide since the mid-1960s. In Norway, treatment was introduced in the 1990s.

More information: Jannike M. Andersen, Christine F. Olaussen, Åse Ripel and Jørg Mørland. Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue. Pharmacology Biochemistry and Behavior, 2011, online publication.

Related Stories

Recommended for you

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.